t(1;10)(p13;q26) FGFR2/AHCYL1

0000-00-00   Jean-Loup Huret , Philippe Dessen 

(Note: the fusion was discovered by NGS. Many chromosome rearrangement mechanisms such as translocation, inversion,deletion or complex rearrangement may lead to the same fusion)

Note

Non-annotated chromosomal abnormality. Preliminary data :
if you are an author who wish to write a full paper/card on this translocation,go to u00a0How to contribute

Summary

Note

Non-annotated chromosomal abnormality. Preliminary data :
if you are an author who wish to write a full paper/card on this translocation,go to  How to contribute

Genes Involved and Proteins

Gene name

Location

10q26.13

Gene name

Location

1p13.3

Highly cited references

Pubmed IDYearTitleCitations
307533362019Kras-driven heterotopic tumor development from hepatobiliary organoids.14
241228102014Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.147

Bibliography

Pubmed IDLast YearTitleAuthors
241228102014Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma.Arai Y et al

External Links

Citation

Jean-Loup Huret ; Philippe Dessen

t(1;10)(p13;q26) FGFR2/AHCYL1

Atlas Genet Cytogenet Oncol Haematol. 0000-00-00

Online version: http://atlasgeneticsoncology.org/solid-tumor/104092/t(1;10)(p13;q26)-fgfr2-ahcyl1